These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Toxicity and pharmacology of extracts from dorid nudibranches. Fuhrman FA; Fuhrman GJ; DeRiemer K Biol Bull; 1979 Jun; 156(3):289-99. PubMed ID: 454700 [TBL] [Abstract][Full Text] [Related]
5. Doridosine derivatives: binding at adenosine receptors and in vivo effects. Tao PL; Yen MH; Shyu WS; Chern JW Eur J Pharmacol; 1993 Oct; 243(2):135-9. PubMed ID: 8276062 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytostatic screening of an SO2 analogue of doridosine. Goya P; MartÃnez A Arch Pharm (Weinheim); 1988 Feb; 321(2):99-101. PubMed ID: 3369933 [No Abstract] [Full Text] [Related]
7. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity. Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567 [TBL] [Abstract][Full Text] [Related]
8. Studies on the hypotensive and bradycardic effects of 1-piperidinylmethyl-2-naphthol hydrochloride. Shen AY; Huang MH; Wang TS Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):209-20. PubMed ID: 9467829 [TBL] [Abstract][Full Text] [Related]
9. Some in vitro and in vivo cardiovascular effects of Hypoxis hemerocallidea Fisch & CA Mey (Hypoxidaceae) corm (African potato) aqueous extract in experimental animal models. Ojewole JA; Kamadyaapa DR; Musabayane CT Cardiovasc J S Afr; 2006; 17(4):166-71. PubMed ID: 17001418 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate. Yamaura T; Kase N; Kita H; Uematsu T Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142 [TBL] [Abstract][Full Text] [Related]
12. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities. Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234 [TBL] [Abstract][Full Text] [Related]
13. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex. Yamano M; Ito H; Kamato T; Miyata K Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711 [TBL] [Abstract][Full Text] [Related]
14. Hypotensive and antiarrhythmic effects of a new alkaloid, the 13-hydroxylupanine-2-pyrrolcarbonic acid ester, from the Madagascan plant Cadia ellisiana. Lindner E; Kaiser J; Schacht U Arzneimittelforschung; 1976; 26(9):1651-7. PubMed ID: 11808 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action. Mutafova-Yambolieva V; Staneva-Stoytcheva D Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):551-7. PubMed ID: 2906393 [TBL] [Abstract][Full Text] [Related]
16. Hypotensive effect of the hydroalcoholic extract from Jacaranda mimosaefolia leaves in rats. Nicasio P; Meckes M J Ethnopharmacol; 2005 Feb; 97(2):301-4. PubMed ID: 15707769 [TBL] [Abstract][Full Text] [Related]
17. [Dopaminergic stimulants: a new type of antihypertensive drug without cardiac repercussions?]. Palop V; MartÃnez-Mir I; Rubio E; Morales-Olivas FJ Rev Esp Cardiol; 1984; 37(5):316-21. PubMed ID: 6494541 [No Abstract] [Full Text] [Related]
18. Synthesis and pharmacological evaluation of N-acyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents. Kubota H; Watanabe T; Kakefuda A; Masuda N; Wada K; Ishii N; Sakamoto S; Tsukamoto S Bioorg Med Chem; 2004 Mar; 12(5):871-82. PubMed ID: 14980599 [TBL] [Abstract][Full Text] [Related]
19. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent. Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate. Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]